By Dr Dongli Liu

Journal articles

Cortesi M; Li J; Liu D; Guo T; Dokos S; Warton K; Ford CE, 2026, 'An accurate and automated approach for the quantification of single-cell adhesion dynamics from microscopy images', Biophysics Reviews, 7, http://dx.doi.org/10.1063/5.0293339

Gunther K; Liu D; Cortesi M; Powell E; Nesbitt-Hawes E; Abbott JA; Ford CE, 2026, 'Patient-derived epithelial cell organoids mimic the phenotypic complexity of endometriosis subtypes', Human Reproduction, 41, pp. 262 - 274, http://dx.doi.org/10.1093/humrep/deaf230

Liu D; Wong-Brown M; Sarker FA; Matthews B; Morrison J; Dickson KA; Alghalayini A; Stojanova J; Wan KM; Duggan J; Loo C; Stannard G; Powell E; Hodder B; Barlow E; Marsh DJ; Ford CE; Bowden NA, 2026, 'Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer', Therapeutic Advances in Medical Oncology, 18, http://dx.doi.org/10.1177/17588359251409010

Liu D; Garikapati S; Wong-Brown M; Bowden NA; Stannard G; Hodder B; Wan KM; Xie HE; Mylvaganam G; Odgers H; Loo C; Ford CE, 2026, 'Utilisation of an integrated drug repurposing pipeline to treat ROR1 expressing endometrial cancer', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 36, http://dx.doi.org/10.1016/j.ijgc.2025.103011

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford CE, 2025, 'Development and validation of a computational tool to predict treatment outcomes in cells from high-grade serous ovarian cancer patients', Bioengineering and Translational Medicine, 10, http://dx.doi.org/10.1002/btm2.70082

Gunther K; Fisher T; Liu D; Abbott J; Ford CE, 2025, 'Endometriosis is not the endometrium: Reviewing the over-representation of eutopic endometrium in endometriosis research', , 14, pp. e103825, http://dx.doi.org/10.7554/elife.103825

Gunther K; Liu D; Stannard G; Holmes M; Loo C; Guo B; Bowden N; Abbott J; Ford CE, 2025, 'An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target', Frontiers in Pharmacology, 16, http://dx.doi.org/10.3389/fphar.2025.1716062

Liu D; Vandenberg CJ; Sini P; Waldmeier L; Baumgartinger R; Pisarsky L; Petroczi G; Ratnayake G; Scott CL; Ford CE, 2025, 'The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models', Therapeutic Advances in Medical Oncology, 17, http://dx.doi.org/10.1177/17588359251332471

Liu D; Glubb D; O'Mara T; Ford CE, 2025, 'The Multi-Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre-Clinical Efficacy in Endometrial Cancer', Cancer Medicine, 14, http://dx.doi.org/10.1002/cam4.70531

Matthews B; Wong-Brown M; Liu D; Yee C; Dickson KA; Schneider J; Islam S; Head R; Martin JH; Ford CE; Marsh DJ; Bowden NA, 2024, 'Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer', Molecular Therapy Oncology, 32, http://dx.doi.org/10.1016/j.omton.2024.200911

Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, 2024, 'Author Correction: A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models (Scientific Reports, (2023), 13, 1, (15769), 10.1038/s41598-023-42486-3)', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-023-50403-x

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, 2024, 'Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202400034

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, 2024, 'Accurate Identification of Cancer Cells in Complex Pre‐Clinical Models Using a Deep‐Learning Neural Network: A Transfection‐Free Approach (Adv. Biology 11/2024)', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202470112

Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, 2023, 'A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-42486-3

Fivelman B; Liu D; Ford C; Wan M; Loo C, 2023, 'Mixed large cell neuroendocrine carcinoma and high grade serous carcinoma of the ovary: a histopathological case report', Pathology, 55, pp. s55, http://dx.doi.org/10.1016/j.pathol.2022.12.178

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2022, 'Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (Scientific Reports, (2020), 10, 1, (13906), 10.1038/s41598-020-70924-z)', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-15043-7

Liu D; Kaufmann GF; Breitmeyer JB; Dickson KA; Marsh DJ; Ford CE, 2022, 'The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14040837

Liu D; Sharbeen G; Phillips P; Johns AL; Gill AJ; Chantrill LA; Timpson P; Chou A; Pajic M; Dwarte T; Herrmann D; Vennin C; Cox TR; Pereira B; Ritchie S; Reed DA; Chambers CR; Metcalf X; Nobis M; Waddell N; Pearson JV; Patch AM; Nones K; Newell F; Mukhopadhyay P; Addala V; Kazakoff S; Holmes O; Leonard C; Wood S; Grimmond SM; Hofmann O; Samra JS; Pavlakis N; Arena J; High HA; Asghari R; Merrett ND; Das A; Cosman PH; Ismail K; Stoita A; Williams D; Spigellman A; Lam VW; McLeod D; Kirk J; Kench JG; Grimison P; Sandroussi C; Goodwin A; Mead RS; Tucker K; Andrews L; Texler M; Forrest C; Ballal M; Fletcher D; Beilin M; Feeney K; Epari K; Mukhedkar S; Zeps N; Nguyen NQ; Ruszkiewicz AR; Worthley C; Chen J; Brooke-Smith ME; Papangelis V; Clouston AD; Barbour AP; O’Rourke TJ; Fawcett JW; Slater K; Hatzifotis M; Hodgkinson P; Nikfarjam M; Eshleman JR; Hruban RH; Wolfgang CL; Scarpa A; Lawlor RT; Corbo V; Bassi C; Biankin AV; Jamieson NB; Chang DK; Dreyer SB; Ford CE, 2021, 'ROR1 and ROR2 expression in pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08952-9

Joshi N; Liu D; Dickson KA; Marsh DJ; Ford CE; Stenzel MH, 2021, 'An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles', Journal of Materials Chemistry B, 9, pp. 9123 - 9135, http://dx.doi.org/10.1039/d1tb01837j

Werner B; Yuwono N; Duggan J; Liu D; David C; Srirangan S; Provan P; DeFazio A; Arora V; Farrell R; Lee YC; Warton K; Ford C, 2021, 'Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer', Gynecologic Oncology, 162, pp. 720 - 727, http://dx.doi.org/10.1016/j.ygyno.2021.06.028

Liu D; Enriquez L; Ford CE, 2021, 'Ror2 is epigenetically regulated in endometrial cancer', Cancers, 13, pp. 1 - 16, http://dx.doi.org/10.3390/cancers13030383

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2020, 'ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-020-70924-z

Costanzo A; Liu D; Nowson C; Duesing K; Archer N; Bowe S; Keast R, 2019, 'A low-fat diet up-regulates expression of fatty acid taste receptor gene FFAR4 in fungiform papillae in humans: a co-twin randomised controlled trial', British Journal of Nutrition, 122, pp. 1212 - 1220, http://dx.doi.org/10.1017/S0007114519002368

Liu D; Costanzo A; Evans MDM; Archer NS; Nowson C; Duesing K; Keast R, 2018, 'Expression of the candidate fat taste receptors in human fungiform papillae and the association with fat taste function', British Journal of Nutrition, 120, pp. 64 - 73, http://dx.doi.org/10.1017/S0007114518001265

Liu D; Archer N; Duesing K; Hannan G; Keast R, 2016, 'Mechanism of fat taste perception: Association with diet and obesity', Progress in Lipid Research, 63, pp. 41 - 49, http://dx.doi.org/10.1016/j.plipres.2016.03.002

Archer NS; Liu D; Shaw J; Hannan G; Duesing K; Keast R, 2016, 'A comparison of collection techniques for gene expression analysis of human oral taste tissue', Plos One, 11, http://dx.doi.org/10.1371/journal.pone.0152157

Conference Papers

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Abstract 1062: Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody', in Cancer Research, American Association for Cancer Research (AACR), pp. 1062 - 1062, http://dx.doi.org/10.1158/1538-7445.am2021-1062

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 10 April 2021 - 21 May 2021

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2021, 'Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. PO042 - PO042, http://dx.doi.org/10.1158/1557-3265.endomet20-po042

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2020, 'Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A41 - A41, http://dx.doi.org/10.1158/1557-3265.ovca19-a41

Liu D; Archer N; Duesing K; Keast R, 2016, 'Expression of Candidate Fat Taste Receptors in Human Fungiform Papillae', in CHEMICAL SENSES, OXFORD UNIV PRESS, FL, Bonita Springs, pp. E32 - E32, presented at 38th Annual Meeting of the Association-for-Chemoreception-Sciences (AChemS), FL, Bonita Springs, 20 April 2016 - 23 April 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383854300081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Liu D; Powell E; Wan KM; Athavale R; Loo C; Ford CE, 2024, 'Abstract B014: Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), Vol. 30, pp. b014 - b014, http://dx.doi.org/10.1158/1557-3265.endo24-b014

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR2 is epigenetically regulated in endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 27, presented at AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, ELECTR NETWORK, 09 November 2020 - 10 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000617951200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR1: A novel target in endometrial cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-2942

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2019, 'ROR1 is associated with ovarian cancer progression and chemoresistance.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 59 - 60, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Cortesi M; Li J; Liu D; Guo T; Dokos S; Warton K; Ford CE, A novel approach for the quantification of single-cell adhesion dynamics from microscopy images, http://dx.doi.org/10.1101/2024.10.08.616409

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, Accurate identification of cancer cells in complex pre-clinical models using deep-learning: a transfection-free approach, http://dx.doi.org/10.1101/2023.10.15.562411

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford CE, Development and validation of a computational tool to predict treatment outcomes in cells from High-Grade Serous Ovarian Cancer patients, http://dx.doi.org/10.1101/2024.10.02.616212

Matthews B; Wong-Brown M; Liu D; Yee C; Dickson K-A; Schneider J; Islam S; Head R; Martin J; Ford C; Marsh D; Bowden N, Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer, http://dx.doi.org/10.22541/au.169580899.90269470/v1

Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, Model Parameter identification using 2D vs 3D experimental data: a comparative analysis, http://dx.doi.org/10.1101/2023.05.17.541071

Back to profile page